Tumor regression and growth rates determined in five intramural NCI prostate cancer trials. The growth rate constant as an indicator of therapeutic efficacy

PURPOSE: In solid tumors such as prostate cancer, novel paradigms are needed to assess therapeutic efficacy. We utilized a method estimating tumor growth and regression rate constants from serial PSA measurements, and assessed its potential in patients with metastatic castration resistant prostate c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cancer Res
Autors principals: Stein, Wilfred D., Gulley, James L., Schlom, Jeff, Madan, Ravi A., Dahut, William, Figg, William D., Ning, Yang-min, Arlen, Phil M., Price, Doug, Bates, Susan E., Fojo, Tito
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6667189/
https://ncbi.nlm.nih.gov/pubmed/21106727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-1762
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars